Lupin launches asthma drug delivery device in US

Last Updated: Wednesday, February 18, 2015, 17:54

The agreement grants Lupin exclusive rights to promote, distribute and market InspiraChamber VHC in the US, it added.

Lupin ties up with Poland-based firm for generic asthama drug

Last Updated: Tuesday, February 17, 2015, 15:54

Drug major Lupin has inked a pact with Poland-based Celon Pharma to jointly develop and market a generic version GlaxoSmithKline's Advair Diskus, a drug used to treat asthama, in global markets.

RBI allows FIIs to invest upto 49% of paid up capital in Lupin

Last Updated: Thursday, February 12, 2015, 21:37

The Reserve Bank on Thursday said foreign institutional investors and registered foreign portfolios investors can now invest up to 49 percent of the paid-up capital in Lupin Ltd under Portfolio Investment Scheme (PIS).

Lupin gets USFDA approval for diarrhoea drug

Last Updated: Monday, February 2, 2015, 15:42

"Lupin Pharmaceuticals Inc (LPI), the company's US subsidiary would commence marketing the product shortly," it added.

Govt allows Lupin to hike FII limit cap to 49%

Last Updated: Wednesday, January 28, 2015, 21:08

The government Wednesday allowed drug maker Lupin to raise the cap of foreign institutional investor holding to 49 percent, a move that would facilitate an inflow of Rs 6,099 crore.

Aurobindo, Lupin & Jubilant get USFDA nod for hypertension drug

Last Updated: Tuesday, January 6, 2015, 19:47

Three domestic firms, Aurobindo Pharma, Lupin and Jubilant Life Sciences, have received final approval from US health regulator to sell generic copies of Valsartan tablets used for treatment of hypertension.

Lupin eyes acquisitions in US, Europe

Last Updated: Sunday, December 28, 2014, 13:56

Drug major Lupin is eyeing acquisitions in various global markets, including the US, Latin America and Europe, as it looks to bolster its presence overseas.

Lupin gets USFDA approval for HIV drug

Last Updated: Friday, December 26, 2014, 16:04

Drug major Lupin has received US health regulator's approval to market a generic version of ViiV Healthcare's Epivir Tablets, used in treating HIV infection, in the American market.

Scouting for acquisitions in India: Lupin

Last Updated: Sunday, December 14, 2014, 14:53

Homegrown drug major Lupin is looking to acquire companies and launch new products in the domestic market as it aims to scale up its Indian operations.

Indian cos in FDA's first list for generic Aciphex tablets

Last Updated: Sunday, November 10, 2013, 13:14

In a decision that will cheer the domestic pharma industry, Indian firms including Dr Reddy's, Lupin and Torrent Pharma have received nod from the US health regulator to market the first generic version of Aciphex, used to treat gastroesophageal reflux disease (GERD).

Lupin gets USFDA nod for generic oral contraceptive drug

Last Updated: Friday, September 27, 2013, 18:12

Drug major Lupin on Friday said it has received US health regulator's approval to market a generic version of Warner Chilcott Company, LLC's 'Ovcon 35' tablets, an oral contraceptive, in the American market.

Lupin signs pact with Onset to sell skin disease lotion in US

Last Updated: Monday, September 23, 2013, 18:15

The strategic co-promotion agreement has been signed between the comapany, its US subsidiary, Lupin Pharmaceuticals Inc and Onset Dermatologics, Lupin said in a statement.